Travere Therapeutics TVTX
NASDAQ TVTX
$51.99 +0.36 (+0.70%)
At close: Nov 10, 2026 · 4:00 PM EST

Travere Therapeutics (TVTX) Operating Margin (2013 - 2026)

Updated

Travere Therapeutics (TVTX) recorded Operating Margin of -30.33% in Q3 2026, down 45.45 percentage points from 15.12% a year earlier and down 32.66 percentage points from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Operating Margin (2013 - 2026) Analysis & Trends

On a TTM basis, Travere Therapeutics' Operating Margin came in at -20.50% as of Sep 30, 2026, up 0.40 percentage points year-over-year; for FY2025, it was -12.80%, up 126.08 percentage points from FY2024.

  • Annual Operating Margin has increased for three straight years, with a five-year change of +76.03 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -138.88% in FY2024 (+128.37 pp), -267.24% in FY2023 (+24.93 pp) and -292.17% in FY2022.
  • The Q3 2026 figure is the lowest quarterly Operating Margin since Q1 2025.
  • On a year-over-year basis, Operating Margin rose in seven of the last eight quarters, with an average year-over-year change of +84.75 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 411.57 percentage points in Q4 2022, against a drop of 474.55 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at 2.33% (Q2 2026), -29.02% (Q1 2026) and -25.00% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 24.35%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 36.01%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 32.97%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 20.57%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.79%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 41.71%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 32.98%
10 Travere Therapeutics 4.85 Bn 4.44 Bn 221.70 Mn -30.33%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -30.33%
Jun 30, 2026 2.33%
Mar 31, 2026 -29.02%
Dec 31, 2025 -25.00%
Sep 30, 2025 15.12%
Jun 30, 2025 -11.05%
Mar 31, 2025 -52.21%
Dec 31, 2024 -81.21%
Sep 30, 2024 -89.27%
Jun 30, 2024 -125.11%
Mar 31, 2024 -336.53%
Dec 31, 2023 -209.13%
Sep 30, 2023 -249.59%
Jun 30, 2023 -322.87%
Mar 31, 2023 -315.23%
Dec 31, 2022 -295.52%
Sep 30, 2022 -294.23%
Jun 30, 2022 -274.24%
Mar 31, 2022 -307.45%
Dec 31, 2021 -707.08%
API Access

Travere Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY